Related Experiment Video
Updated: Mar 27, 2026

07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
905
Rapid and robust reversion to essential thrombocythemia on treatment with Decitabine in a case of hydroxyurea-induced
Joshua D Horton1, Arnaldo A Arbini2, Mary Ann Perle2
1New York University School of Medicine 550 First Avenue New York New York 10010.
Clinical Case Reports
|January 20, 2016
Abstract:
Rapid remission of MDS/AML may be induced with Decitabine; however, significant megakaryocyte expansion and subsequent thrombocytosis may occur. Decitabine-mediated reversion of the MDS to benign ET via hypomethylation of JAK/STAT pathway repressors is one potential mechanism to explain this observed phenomenon.
Keywords:
Acute leukemiachemotherapyessential thrombocythemiahydroxyurealeukemia cytogeneticsmegakaryocyteMore Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
325
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
325
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

